Evander A, Lundquist I, Ihse I
Eur Surg Res. 1984;16(4):249-55. doi: 10.1159/000128416.
In short-term experiments (25 or 72 h) oral trypsin inhibitor administration to pancreatitic rats significantly decreased survival rate, whereas oral trypsin administration had no effect in this respect. Neither treatment influenced the activities of amylase in serum, pancreatic tissue or ascites. Trypsin given in excess together with the trypsin inhibitor abolished the deleterious effects on survival caused by the trypsin inhibitor. In a long-term experiment in healthy rats oral trypsin inhibitor ingestion caused a significant increase in pancreatic wet weight, protein concentration and activities of amylase, lipase and trypsinogen in pancreatic tissue; again, trypsin administration had no effect. The data support the idea that oral trypsin inhibitor administration causes release of cholecystokinin (CCK) or CCK-like factors from the intestine by interfering with the negative feedback regulation exerted by intraluminal trypsin. The results of the short-term experiments further indirectly suggest that even small amounts of trypsin within the intestine - as in acute pancreatitis - can exert the feedback regulation. Finally, the results of the long-term experiment suggest that oral administration of trypsin does not exert any suppressive effects on pancreatic wet weight and pancreatic enzyme content.
在短期实验(25小时或72小时)中,给胰腺炎大鼠口服胰蛋白酶抑制剂会显著降低存活率,而口服胰蛋白酶在这方面则没有影响。两种处理均未影响血清、胰腺组织或腹水中淀粉酶的活性。过量给予胰蛋白酶与胰蛋白酶抑制剂一起可消除胰蛋白酶抑制剂对存活率造成的有害影响。在一项针对健康大鼠的长期实验中,口服胰蛋白酶抑制剂会导致胰腺湿重、蛋白质浓度以及胰腺组织中淀粉酶、脂肪酶和胰蛋白酶原的活性显著增加;同样,给予胰蛋白酶也没有影响。这些数据支持这样一种观点,即口服胰蛋白酶抑制剂通过干扰肠腔内胰蛋白酶施加的负反馈调节,导致胆囊收缩素(CCK)或CCK样因子从肠道释放。短期实验的结果进一步间接表明,即使肠道内存在少量胰蛋白酶——如在急性胰腺炎中——也能发挥反馈调节作用。最后,长期实验的结果表明,口服胰蛋白酶对胰腺湿重和胰腺酶含量没有任何抑制作用。